Gabriel D Olander

Array ( [id] => 2293800 [patent_doc_number] => 04652548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-03-24 [patent_title] => 'Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin' [patent_app_type] => 1 [patent_app_number] => 6/682204 [patent_app_country] => US [patent_app_date] => 1984-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6554 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/652/04652548.pdf [firstpage_image] =>[orig_patent_app_number] => 682204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2362155 [patent_doc_number] => 04665088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-05-12 [patent_title] => '(E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides' [patent_app_type] => 1 [patent_app_number] => 6/671320 [patent_app_country] => US [patent_app_date] => 1984-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2451 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/665/04665088.pdf [firstpage_image] =>[orig_patent_app_number] => 671320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2302831 [patent_doc_number] => 04642314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-02-10 [patent_title] => 'Antiulcer compounds' [patent_app_type] => 1 [patent_app_number] => 6/671237 [patent_app_country] => US [patent_app_date] => 1984-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7159 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/642/04642314.pdf [firstpage_image] =>[orig_patent_app_number] => 671237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2324567 [patent_doc_number] => 04636503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-01-13 [patent_title] => 'Dust-free quinoxaline 1,4-di-N-oxides' [patent_app_type] => 1 [patent_app_number] => 6/667652 [patent_app_country] => US [patent_app_date] => 1984-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1698 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/636/04636503.pdf [firstpage_image] =>[orig_patent_app_number] => 667652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2243836 [patent_doc_number] => 04613498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-09-23 [patent_title] => 'Hemorrhoid medication' [patent_app_type] => 1 [patent_app_number] => 6/664313 [patent_app_country] => US [patent_app_date] => 1984-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1073 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/613/04613498.pdf [firstpage_image] =>[orig_patent_app_number] => 664313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2447169 [patent_doc_number] => 04767610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-08-30 [patent_title] => 'Method for detecting abnormal cell masses in animals' [patent_app_type] => 1 [patent_app_number] => 6/662728 [patent_app_country] => US [patent_app_date] => 1984-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1911 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/767/04767610.pdf [firstpage_image] =>[orig_patent_app_number] => 662728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361207 [patent_doc_number] => 04657917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-14 [patent_title] => 'Platelet aggregation inhibitory agents' [patent_app_type] => 1 [patent_app_number] => 6/662533 [patent_app_country] => US [patent_app_date] => 1984-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 9295 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/657/04657917.pdf [firstpage_image] =>[orig_patent_app_number] => 662533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2289564 [patent_doc_number] => 04639333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-01-27 [patent_title] => 'Process for converting preproinsulin analogs into insulins' [patent_app_type] => 1 [patent_app_number] => 6/659865 [patent_app_country] => US [patent_app_date] => 1984-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2301 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/639/04639333.pdf [firstpage_image] =>[orig_patent_app_number] => 659865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2293037 [patent_doc_number] => 04659713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-21 [patent_title] => 'Quinoxalinedione compounds useful for controlling coccidiosis' [patent_app_type] => 1 [patent_app_number] => 6/656391 [patent_app_country] => US [patent_app_date] => 1984-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2399 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/659/04659713.pdf [firstpage_image] =>[orig_patent_app_number] => 656391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2279551 [patent_doc_number] => 04601852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-07-22 [patent_title] => 'Process for the preparation of human or the derivatives thereof from pig insulin or the derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 6/641357 [patent_app_country] => US [patent_app_date] => 1984-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2735 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/601/04601852.pdf [firstpage_image] =>[orig_patent_app_number] => 641357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2322275 [patent_doc_number] => 04670428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-06-02 [patent_title] => 'Method for treating convulsions and epilepsy with organic copper compounds' [patent_app_type] => 1 [patent_app_number] => 6/640731 [patent_app_country] => US [patent_app_date] => 1984-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9970 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/670/04670428.pdf [firstpage_image] =>[orig_patent_app_number] => 640731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2278300 [patent_doc_number] => 04610993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-09-09 [patent_title] => 'Use of selected pyridine-N-oxide disulfide compounds to treat or prevent bovine mastitis' [patent_app_type] => 1 [patent_app_number] => 6/638808 [patent_app_country] => US [patent_app_date] => 1984-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/610/04610993.pdf [firstpage_image] =>[orig_patent_app_number] => 638808 [rel_patent_id] =>[rel_patent_doc_number] =>)